Aids
Times have changed since AIDS conference last held in Montreal
The International AIDS Conference, now 37 years old, is the longest standing comprehensive conference addressing the full spectrum of developments in controlling the spread of HIV infection globally.
New clinical trial will test three mRNA vaccine candidates for HIV
The National Institute of Allergy and Infectious Diseases announced Monday that it has initiated a phase 1 clinical trial of three experimental messenger RNA HIV vaccines.
Discovery of ‘highly virulent’ HIV variant ‘not a public health crisis’
Researchers discovered what they described as a “highly virulent” variant of HIV-1 that has been circulating in the Netherlands for the past 2 decades.
AKI incidence between 2005, 2015 in patients with HIV on antiretroviral therapy fluctuated
White House marks World AIDS Day with updated national HIV strategy
On Wednesday, the White House marked World AIDS Day 2021 by releasing an updated national strategy to bolster the fight against HIV.
‘Substantial efforts’ needed to reach viral suppression target for children with HIV
Globally, children and adolescents on ART lag adults in progress toward achieving viral suppression, according to new data published in The Lancet HIV ahead of World AIDS Day, which is Dec. 1.
Study offers reassuring findings on HIV-to-HIV transplants
HIV-to-HIV transplantation is on the rise, and there are many donors with good organ quality and an acceptable risk profile in terms of post-transplant ART for prevention of HIV superinfection, according to a recent study.
Patients on failing HIV regimens achieve viral suppression with long-acting lenacapavir
Subcutaneous lenacapavir in combination with an optimized background regimen led to sustained virologic suppression in 81% of heavily treated people with HIV at week 26, data from an ongoing phase 2/3 study showed.
Prevalence of transmitted resistance to common HIV drugs remains stable
The prevalence of transmitted resistance to common HIV drugs in the United States remained stable between 2014 and 2018, according to a study published recently in Clinical Infectious Diseases.
PrEP disparities worsened in recent years, study finds
A retrospective analysis showed increasing disparities in HIV PrEP uptake between early and late adopting states between 2014 and 2018, researchers reported.